Cargando…

The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial

AIM: This study aimed to compare the effect of the same volume of moderate- and high-intensity aerobic exercise on patients' liver steatosis and fibrosis. BACKGROUND: Exercise is known strategy to deal with non-alcoholic fatty liver disease (NAFLD). METHODS: This Randomized Control Trial was pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassabi, Mohammad, Sadeghi, Amir, Abedy Yekta, Amir Hosein, Salehi, Shahin, Mahdaviani, Behnaz, Asgari, Ahmadreza, Poursaeid Esfahani, Mehrshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105501/
https://www.ncbi.nlm.nih.gov/pubmed/37070113
http://dx.doi.org/10.22037/ghfbb.v16i1.2466
_version_ 1785026222009352192
author Hassabi, Mohammad
Sadeghi, Amir
Abedy Yekta, Amir Hosein
Salehi, Shahin
Mahdaviani, Behnaz
Asgari, Ahmadreza
Poursaeid Esfahani, Mehrshad
author_facet Hassabi, Mohammad
Sadeghi, Amir
Abedy Yekta, Amir Hosein
Salehi, Shahin
Mahdaviani, Behnaz
Asgari, Ahmadreza
Poursaeid Esfahani, Mehrshad
author_sort Hassabi, Mohammad
collection PubMed
description AIM: This study aimed to compare the effect of the same volume of moderate- and high-intensity aerobic exercise on patients' liver steatosis and fibrosis. BACKGROUND: Exercise is known strategy to deal with non-alcoholic fatty liver disease (NAFLD). METHODS: This Randomized Control Trial was performed on 60 patients randomly assigned to three arms of the study (1:1:1). Fibrosis and steatosis of liver including Control Attenuated Parameter (CAP) determined using Transient Elastography (TE). The control group was advised to adjust their lifestyle, as a routine management. The intervention groups additionally, participated on supervised exercise programs with two different intensities but the same volume of 1000 KCal per week. The intensities of 50% and 70% of V02 reserve were considered for moderate-intensity and vigorous programs, respectively. RESULTS: On six-month follow-up, none of outcomes were statistically significant among three arms of study. However, changes in some outcomes were reached to statistically significant difference in follow-up in comparison with baseline. The mean of CAP score changes was -19.43 (31.43) (P=0.03), 9.92 (26.81) (P=0.21), and 14.61 (18.03) (P=0.01) in control, moderate- and high-intensity groups, respectively. In the high-intensity group, in addition to steatosis, this difference was also observed in the rate of fibrosis. Besides, the level of serum aminotransferases in the group with moderate exercise after six months had a significant decrease compared to baseline. (P=0.01) CONCLUSION: Improvement in steatosis and fibrosis was more evident in high- intensity group. As the rate of drop out was high, caution is needed in interpretation of the results.
format Online
Article
Text
id pubmed-10105501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-101055012023-04-16 The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial Hassabi, Mohammad Sadeghi, Amir Abedy Yekta, Amir Hosein Salehi, Shahin Mahdaviani, Behnaz Asgari, Ahmadreza Poursaeid Esfahani, Mehrshad Gastroenterol Hepatol Bed Bench Original Article AIM: This study aimed to compare the effect of the same volume of moderate- and high-intensity aerobic exercise on patients' liver steatosis and fibrosis. BACKGROUND: Exercise is known strategy to deal with non-alcoholic fatty liver disease (NAFLD). METHODS: This Randomized Control Trial was performed on 60 patients randomly assigned to three arms of the study (1:1:1). Fibrosis and steatosis of liver including Control Attenuated Parameter (CAP) determined using Transient Elastography (TE). The control group was advised to adjust their lifestyle, as a routine management. The intervention groups additionally, participated on supervised exercise programs with two different intensities but the same volume of 1000 KCal per week. The intensities of 50% and 70% of V02 reserve were considered for moderate-intensity and vigorous programs, respectively. RESULTS: On six-month follow-up, none of outcomes were statistically significant among three arms of study. However, changes in some outcomes were reached to statistically significant difference in follow-up in comparison with baseline. The mean of CAP score changes was -19.43 (31.43) (P=0.03), 9.92 (26.81) (P=0.21), and 14.61 (18.03) (P=0.01) in control, moderate- and high-intensity groups, respectively. In the high-intensity group, in addition to steatosis, this difference was also observed in the rate of fibrosis. Besides, the level of serum aminotransferases in the group with moderate exercise after six months had a significant decrease compared to baseline. (P=0.01) CONCLUSION: Improvement in steatosis and fibrosis was more evident in high- intensity group. As the rate of drop out was high, caution is needed in interpretation of the results. Shaheed Beheshti University of Medical Sciences 2023 /pmc/articles/PMC10105501/ /pubmed/37070113 http://dx.doi.org/10.22037/ghfbb.v16i1.2466 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) which permits others to copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Original Article
Hassabi, Mohammad
Sadeghi, Amir
Abedy Yekta, Amir Hosein
Salehi, Shahin
Mahdaviani, Behnaz
Asgari, Ahmadreza
Poursaeid Esfahani, Mehrshad
The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial
title The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial
title_full The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial
title_fullStr The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial
title_full_unstemmed The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial
title_short The role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial
title_sort role of moderate- and high-intensity supervised aerobic training in reducing steatosis and hepatic fibrosis in patients with non-alcoholic fatty liver disease; a randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105501/
https://www.ncbi.nlm.nih.gov/pubmed/37070113
http://dx.doi.org/10.22037/ghfbb.v16i1.2466
work_keys_str_mv AT hassabimohammad theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT sadeghiamir theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT abedyyektaamirhosein theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT salehishahin theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT mahdavianibehnaz theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT asgariahmadreza theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT poursaeidesfahanimehrshad theroleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT hassabimohammad roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT sadeghiamir roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT abedyyektaamirhosein roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT salehishahin roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT mahdavianibehnaz roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT asgariahmadreza roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial
AT poursaeidesfahanimehrshad roleofmoderateandhighintensitysupervisedaerobictraininginreducingsteatosisandhepaticfibrosisinpatientswithnonalcoholicfattyliverdiseasearandomizedcontrolledtrial